Burgdorf, Switzerland
Burgdorf, Switzerland

Time filter

Source Type

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 - 2022" report to their offering. The research report titled Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 - 2022 examines the market, demand, competitive landscape and trends of the ten major markets of the Insulin Pen Market. Insulin Pen Market is likely to reach more than US$ 12 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022. Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user-friendly design, rising popularity among consumers, help avoid over/under-dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices In terms of prefilled insulin pen users, China is the top prefilled insulin pen consumer, followed by United States and Japan, a trio leading a prefilled insulin pen users share and is expected to witness the highest growth rate in the forecast period United States is expected to lead the insulin pen market with a total market share of over 20% by 2022. China and Japan held the #2 and #3 largest market share and is expected to maintain its dominant position during the forecast period. In terms of Reusable Insulin Pen Market, China and Germany will lead the reusable insulin pen market with more than combined 75% market share by 2022. In terms of Prefilled Insulin Pen Market, United States accounted for the largest share of the insulin pen market in 2016, followed by Japan and Germany. United States is expected to register the highest CAGR during the forecast period. The report concludes with the profiles of major players in the Insulin Pen Market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the Insulin Pen Market. Key Companies Covered in the Report are as follows: For more information about this report visit http://www.researchandmarkets.com/research/pgvbgj/insulin_pen


News Article | April 24, 2017
Site: marketersmedia.com

In terms of Reusable Insulin Pen Market, China and Germany will lead the reusable insulin pen market with more than combined 75% market share by 2022.PUNE, INDIA - April 24, 2017 /MarketersMedia/ — Global Insulin Pen Industry Latest Report on Insulin Pen Market Global Analysis & 2022 Forecast Research Study Insulin Pen Market is likely to reach more than US$ 12 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022. Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices Try Sample Report @ https://www.wiseguyreports.com/sample-request/1214985-insulin-pen-market-size-share-opportunity-analysis-growth-potential-demand-forecast Insulin Pen Users Insights China is the leading consumers of insulin pen where XX% of the diabetic population prefer insulin pen. India and Germany have shown its potential to become 2nd and 3rd popular insulin pen users. United States is the fourth leading consumers of insulin pen. Japan and Brazil hold the fifth and sixth leading consumers of insulin pen. In terms of reusable insulin pen users, China gained its top position as the biggest overall consumer of reusable insulin pen. India and Germany grabbed the #2 and #3 position with XX% and XX% share in 2016 and is likely to maintain its position till the forecast period. Key Companies Covered in the Report are as follows 1. Novo Nordisk 2. Eli Lilly 3. Sanofi 4. Owen Mumford 5. Ypsomed 6. Biocon Ltd. In terms of prefilled insulin pen users, China is the top prefilled insulin pen consumer, followed by United States and Japan, a trio leading a prefilled insulin pen users share and is expected to witness the highest growth rate in the forecast period Insulin Pen Market Insights United States is expected to lead the insulin pen market with a total market share of over 20% by 2022. China and Japan held the #2 and #3 largest market share and is expected to maintain its dominant position during the forecast period. In terms of Reusable Insulin Pen Market, China and Germany will lead the reusable insulin pen market with more than combined 75% market share by 2022. In terms of Prefilled Insulin Pen Market, United States accounted for the largest share of the insulin pen market in 2016, followed by Japan and Germany. United States is expected to register the highest CAGR during the forecast period. For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/1214985-insulin-pen-market-size-share-opportunity-analysis-growth-potential-demand-forecast The research report titled “Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022” examines the market, demand, competitive landscape and trends of the ten major markets of the Insulin Pen Market. The report provides an in–depth analysis of overall diabetes population and insulin users. It provides essential insights into insulin pen users with more focused–on reusable and prefilled insulin pen users. Market outlook in value terms for the forecasted period for Insulin Pen Market has been detailed in the report. The insulin pen market is further segment into reusable and prefilled insulin pen market. The report also explores detailed description of growth drivers and inhibitors of the Insulin Pen Market. The report concludes with the profiles of major players in the Insulin Pen Market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the Insulin Pen Market. All the Ten Major Markets(10MM) Covered in the Report Have Studied from 8 Viewpoints 1. Overall Diabetes Population (2011 – 2022) 2. Insulin Users (2011 – 2022) 3. Insulin Pen Users (2011 – 2022) 4. Reusable (Cartridge) Insulin Pen Users (2011 – 2022) 5. Prefilled (Disposable) Insulin Pen Users (2011 – 2022) 6. Insulin Pen Market (2011 – 2022) 7. Reusable (Cartridge) Insulin Pen Market (2011 – 2022) 8. Prefilled (Disposable) Insulin Pen Market (2011 – 2022) Ten Major Markets(10MM) Covered in the Report are as follows 1. United States 2. United Kingdom 3. France 4. Italy 5. Spain 6. Germany 7. Japan 8. China 9. India 10. Brazil If you have any enquiry before buying a copy of this report @ https://www.wiseguyreports.com/enquiry/1214985-insulin-pen-market-size-share-opportunity-analysis-growth-potential-demand-forecast For more information or any query mail at sales@wiseguyreports.com About Us Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. Contact Us: Norah Trent +1 646 845 9349 / +44 208 133 9349 Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym Contact Info:Name: NORAH TRENTEmail: sales@wiseguyreports.comOrganization: WISE GUY RESEARCH CONSULTANTS PVT LTDSource URL: http://marketersmedia.com/insulin-pen-global-industry-size-share-trends-analysis-and-forecast-2017-2022/189482For more information, please visit https://www.wiseguyreports.com/sample-request/1214985-insulin-pen-market-size-share-opportunity-analysis-growth-potential-demand-forecastSource: MarketersMediaRelease ID: 189482


The research report titled Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 - 2022 examines the market, demand, competitive landscape and trends of the ten major markets of the Insulin Pen Market. Insulin Pen Market is likely to reach more than US$ 12 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022. Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user-friendly design, rising popularity among consumers, help avoid over/under-dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices. In terms of prefilled insulin pen users, China is the top prefilled insulin pen consumer, followed by United States and Japan, a trio leading a prefilled insulin pen users share and is expected to witness the highest growth rate in the forecast period. United States is expected to lead the insulin pen market with a total market share of over 20% by 2022. China and Japan held the #2 and #3 largest market share and is expected to maintain its dominant position during the forecast period. In terms of Reusable Insulin Pen Market, China and Germany will lead the reusable insulin pen market with more than combined 75% market share by 2022. In terms of Prefilled Insulin Pen Market, United States accounted for the largest share of the insulin pen market in 2016, followed by Japan and Germany. United States is expected to register the highest CAGR during the forecast period. The report concludes with the profiles of major players in the Insulin Pen Market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the Insulin Pen Market. Key Companies Covered in the Report are as follows: 1. Executive Summary 2. Insulin Pen Market in Top Ten Countries - Market Overview 3. Insulin Pen Market Drivers and Barriers 4. Insulin Pen Market in Top Ten Countries - Geographical Landscape 5. Key Companies Analysis For more information about this report visit http://www.researchandmarkets.com/research/s58sxk/insulin_pen To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-insulin-pen-market-2017-2022--market-is-likely-to-reach-more-than-us-12-billion-across-the-ten-major-markets-10mm-by-the-year-end-of-2022---research-and-markets-300452159.html


News Article | April 21, 2017
Site: marketersmedia.com

— The global pen needles market is expected to reach a value of USD 4.8 billion by 2025, according to a new report by Grand View Research, Inc. Rising prevalence of diabetes is the primary reason for the significant growth of pen needles market. According to the International Diabetes Federation (IDF), nearly 415 million people were suffering from diabetes in 2015. Such a high prevalence of diabetes across the globe has led to rising demand for pen needles. Patients suffering from diabetes commonly use injectable pen devices, which helps in easy drug delivery. In addition, obesity is a significant cause of diabetes. Obese people often suffer from type 2 diabetes, which makes them one of the highest revenue contributors of the target market. Thus, people with type 2 diabetes are the common target population for companies manufacturing pen needles. Rising technological advancements is also expected to drive the market growth. Pen needles allow comfort and easy mode of insulin delivery. These devices are technologically advanced and provide a superior alternative drug delivery method in comparison to syringes and vials. For instance, in 2013, Becton, Dickinson and Company launched BD Ultra-Fine Nano 4mm Pen Needles with EasyFlow Technology, which will enable diabetic patients with easy adherence of insulin therapy regimens. Further Key Findings from the Study Suggest: Standard needles dominated the market in 2015 due to the availability of cost-effective needles as compared to safety needles. Safety pen needles are anticipated to showcase lucrative growth over the forecast period due to the continuous technological advancements. Amongst the needle lengths, 8mm held the largest share in 2015. This is due to the convenience offered by this needle type on diabetic patients. Needle length of 4mm are expected to witness attractive CAGR over the forecast period owing to its short length. Insulin therapy accounted for the largest market share in 2015 due to rising awareness regarding self-administration of insulin amongst the diabetic patients. Europe dominated the market in 2015 followed by North America owing to high prevalence of diabetes in the European region. Asia Pacific region is anticipated to exhibit the highest growth rate over the forecast period owing to the rising awareness levels amongst the diabetic population regarding easy drug delivery. Some of the key players include Becton, Dickinson and Company, B. Braun Melsungen AG, Novo Nordisk A/S, Owen Mumford, Ltd., Ypsomed, HTL-STREFA, and TERUMO CORPORATION. Chapter One: Research Methodology Chapter Two: Executive Summary Chapter Three: Pen Needles Market Variables, Trends & Scope Chapter Four: Pen Needles: Product Estimates & Trend Analysis Chapter Five: Pen Needles: Needle Length Estimates & Trend Analysis Chapter Six: Pen Needles: Therapy Estimates & Trend Analysis Chapter Seven: Pen Needles: Regional Estimates & Trend Analysis, by Product, Needle Length, Therapy Chapter Eight: Competitive Landscape About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients. For more information, please visit http://www.orbisresearch.com/reports/index/pen-needles-market-analysis-by-product-standard-pen-needles-safety-pen-needles-by-needle-length-4mm-5mm-6mm-8mm-10mm-12mm-by-therapy-insulin-glucagon-like-peptide-1-glp-1-growth-hormone-and-segment-forecasts-2014-2025


Research and Markets has announced the addition of the "Infusion Pumps - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Infusion Pumps in US$ by the following Product Segments: The report profiles 52 companies including many key and niche players such as: - Infusion Pumps: An Alternate Drug Delivery Option - Current and Future Analysis - Developed Economies Dominate Infusion Pumps Market - Asia-Pacific: The Fastest Growing Market for Infusion Pumps - Analysis by Product Segments - Ambulatory Infusion Pumps - Enteral Feeding Pumps - Insulin Infusion Pumps - Large Volume Infusion Pumps - PCA Infusion Pumps - Syringe Infusion Pumps - Infusion Errors & Technology Defenses Developed Over the Years - Rise in Incidence of Chronic Diseases Fuels Infusion Pumps Demand - The Diabetes Epidemic - Untapped Potential for Insulin Pumps - Global Diabetes Expenditure: Opportunity Indicator for Insulin Pumps Market - Cancer Pain Offers Potential Opportunities for Pain Management Pumps - Infusion Pumps - A Highly Consolidated Market - Insulin Pumps Market - Competition Intensifies - Comparison of Select Durable Insulin Pumps by Manufacturer - Medtronic Banks on New Solutions and Distribution Expansion to Retain Dominance - J&J's OneTouch Via - A Discrete Solution for On-Demand Insulin - Ypsomed Eyes Brighter Prospects with YpsoPump - Medtrum - A New Entrant with a Strong Product; Threatening to Take the Market by Storm - Competitive Landscape in the Insulin Patch Pump Market - OmniPod Benefits from Lack of Close Competition in its League - Insulet Focuses on Advances in Technology and Services to Gain Market Share - Cellnovo's Patch Pump Combines Functionality and Cost- Effectiveness - V-Go - An Affordable Patch Pump for Type II Diabetics - Expiry of Warranty Provides New Opportunities to Insulin Pump Makers - Customer Satisfaction: Crucial to Stay Competitive - Enteral Feeding Devices: An Intensely Competitive Market - Multinationals Target Emerging Markets - The New Hotspots for Growth - Infusion Errors: A Key Driving Force for Newer Technologies - Manufacturers Focus on Interoperability with EMR Systems - Security of Wireless Medical Device - A Vital Factor - Shift from Hospital Environments to Alternative-Sites/ Home Settings Drives the market for Home Infusion Pumps - Product Complexity Thwarts ROI on Devices - Smart Pump Technology: A Major Growth Driver - Smart Pumps with Innovative Features - Improving Functionality for Enhanced Patient Compliance - Maintaining Smartness Quotient of Smart Infusion Pumps - Product Bundling: A Double Whammy Success - Analgesia Infusion Pumps Continue to Register Favorable Growth - Disposable Ambulatory Infusion Pumps Market Exhibits Notable Stride Forward - Enteral Feeding Pumps Market Overview - Replacements Offer Potential Growth Opportunities - Preference for Enteral Nutrition over Parenteral Nutrition Bodes Well - Advantages and Disadvantages of Enteral Nutrition over Parenteral Nutrition - Enteral Nutrition Therapy in Treating Adult Malnutrition Offers Growth Opportunities - Home Enteral Therapy to Boost Demand for Enteral Feeding Devices - Insulin Pumps - Designed for Optimum Disease Management - The Rise of Smart Pumps - Manufacturers Eye Type II Diabetes Market - Implantable Insulin Pumps - The Next Generation of Insulin Pumps - Patch Pumps Gain Manufacturer Attention - Insulin Pump Training - An Important Driver - Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged - Competition from Other Insulin Delivery Technologies Continues - Maturity Hits Volumetric Infusion Pumps Market - Equipment Recalls Thwarts Growth Prospects - Stringent Safety Regulations Impede Time-to-Market - Look into Select Technology Advancements - Ivenix Develops Next-Generation Infusion Management Platform - Innovfusion Develops Advanced Infusion Pumps to Provide Relief from Labor Pain - Summit Medical's Low-Cost Portable Infusion Pumps Improve Patient Care - Product Malfunctioning Erodes Penetration of Implantable Infusion Pumps Rise in Healthcare Spending in Developing Nations Bode Well for the Market Aging Population: A Strong Growth Driver Global Aging Population Statistics Opportunity Indicators Rise in Incidence of Cancer and Central Nervous System Diseases Foster Growth World Cancer Statistics: Incidence and Mortality Data Diabetes Incidence and Prevalence Global Diabetic Statistics Opportunity Indicators Alarming Rise in Obesity A Business Case for Diabetes Care Rise in HIV Prevalence Provides Ample Growth Opportunities Global HIV Statistics Opportunity Indicators for Enteral Feeding Devices - FDA Announces Initiative to Address Safety Concerns Related to Infusion Pumps - FDA Announces a New Mandate for Manufacturing Companies - Regulations Promote Adoption of Premium-Priced Safety Devices - ISO 80369 Standards for Small-Bore Connector - ENFit - The New ISO Standard Enteral Feeding Connecting System - Infusion Pumps: A Definition - Types of Infusion Pumps - Ambulatory Infusion Pumps - Non-Electronic Ambulatory Infusion Pumps - Advantages & Disadvantages of Non-Electronic Pumps - Electronic Ambulatory Infusion Pumps - Nerve Block Infusion Pumps - Enteral Feeding Pumps - Insulin Infusion Pumps - Large Volume Infusion Pumps - Pump Architecture of Volumetric Pumps - Classification by End-Use Application - Volumetric Pumps used in Acute Care Settings - Volumetric Pumps used in Alternate Care Settings - Patient Controlled Analgesic (PCA) Pumps - Syringe Infusion Pumps - Low-End and High-End Syringe Pumps - Implantable Infusion Pumps - Programmable Implantable Infusion Pumps - Constant Flow Implantable Infusion Pumps - Approved Applications of Implantable Infusion Pumps - Common Safety Features Available In Most Infusion Pumps - Key Problems Reported with Infusion Pumps - User Interface Issues - Software Issues - Alarm Errors - Damaged Components - Battery Failures - Fire, Shocks, Sparks or Charring - Intelligraphics Enters into Collaboration with Ivenixto Develop Intelligent Infusion Pump Platform - Smiths Medical Introduces New Software Version for use with Medfusion® 4000 wireless syringe pumps - Caesarea Medical Announces Launch of its latest Dual Channel Infusion Pump - Medtronic Launches MiniMed® 630G System - Hospira Introduces LifeCare PCA 7.0 infusion pump with EMR Connectivity - Smiths Medical Launches New CADD®-Solis Pump - Animas Bags FDA Approval for Animas® Vibe® Insulin Pump and Continuous Glucose Monitoring System - Medtronic Rolls Out MiniMed 640G Insulin Pump - B. Braun Medical Secures FDA Approval for Infusomat® Space Pump - Zyno Medical Gains CE Mark Approval for Z-800 Infusion Pump System - Hospira Receives FDA Clearance for Plum 360 Infusion System - BioLeonhardt Develops Stem Cell Pump - Animas Rolls Out Animas® Vibe Insulin Pump with Latest Dexcom CGM Technology - Baxter Gets FDA Clearance for SIGMA Spectrum Infusion Pump with Master Drug Library - Animas Bags CE Mark Approval for Animas® Vibe Insulin Pump and Dexcom G4 PLATINUM CGM System - Animas Secures FDA Approval for Animas® Vibe Insulin Pump and Continuous Glucose Monitoring System Omnicell and Hospira Collaborate for System Interoperability BD Enters into Collaboration with JDRF to Develop Extended Wear Innovations for Insulin Infusion Delivery Teleflex Signs Group Purchasing Agreement with Premier Inc. for Implantable Infusion Ports ICU Medical to Acquire Pfizer's Infusion Therapy Business Zyno Medical Receives FDA 510(k) Clearance for Nimbus II Ambulatory Infusion System InfuSystem to Acquire Infusion Pump Assets from InfusAID, LLC Medtronic to Manufacture and Deploy Advanced Diabetes Therapies in Chengdu, China Pfizer Considers Sale of the Infusion Pump Business Pfizer Acquires Hospira InfuSystem Completes Acquisition of Ciscura Becton Dickinson Takes Over CareFusion Hospira Inks Agreement with Cerner for Developing Infusion Pump Information Platform Animas Partners with Tidepool Medtronic Partners with BD to Develop New Insulin Pump with BD FlowSmart Technology Fresenius Kabi Inks Agreement with Amerinet Hospira Faces Class I Recall of GemStar Infusion System - Animas Corporation (USA) - Baxter International Inc. (USA) - B. Braun Melsungen AG (Germany) - Becton, Dickinson and Company (USA) - F. Hoffmann-La Roche Ltd. (Switzerland) - Fresenius SE & Co. KGaA (Germany) - Halyard Health, Inc. (USA) - Hospira, Inc. (USA) - ICU Medical, Inc. (USA) - Insulet Corporation (USA) - Medtronic, PLC (Ireland) - Moog, Inc. (USA) - Smiths Medical (USA) - Sooil Development Co. Ltd. (Korea) - Tandem Diabetes Care, Inc. (USA) - Teleflex Incorporated (USA) - Terumo Corporation (Japan) - The United States - Japan - Europe - France - Germany - The United Kingdom - Rest of Europe - Asia-Pacific (Excluding Japan) - Middle East - Latin America For more information about this report visit http://www.researchandmarkets.com/research/cq3cv2/infusion_pumps


Global Self-Injections Market Forecast to 2024 - New Report by Data Bridge Market Research Global Self-Injections Market, By Type (Devices (Needle-Free, Auto, Pen, Wearable Injectors), Formulations), Dosage Form, Therapeutic Application, Route of Administration, End-User, Distribution Channel, Geography (North America, Europe, APAC, MEA, South America) – Trends and Forecast to 2024 Dallas, TX, February 24, 2017 --( The self-injections market is segmented based on type, dosage form, therapeutic application, route of administration, end-user, distribution channel, and geography. On the basis of type, the global self-injections market is segmented into devices and formulations. The devices market is segmented into needle-free injectors, auto injectors, pen injectors, wearable injectors, and other devices. The needle-free injectors market is further segmented on the basis of product, technology, and usability. The product segment is categorized into fillable and prefilled. The auto-injectors market is segmented into product, technology, design, and usability. The product segment is categorized into fillable and prefilled. The pen-injectors market is segmented into product, design, and usability. The product segment is categorized into single-chambered and dual-chambered. The design segment is further categorized into standard and customized. Based on therapeutic application, the market is segmented intoautoimmunediseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, and others. The market is also segmented based on dosage formintosingle dose and multi-dose. On the basis of route of administration, the market is segmented into skin, circulatory /musculoskeletal, organs, and central nervous system. On the basis of end-user, the market is segmented into patient, physicians, home care settings and, others. The market is also segmented on the basis of distribution channel into hospital pharmacies, private clinics, chemist, and online pharmacies. Request for sample pages: https://databridgemarketresearch.com/reports/global-self-injections-market-trends-forecast-2024/ Based on geography, the self-injections market is segmented into geographical regions such as North America, Europe, Asia-Pacific, South America, Middle East and Africa and, Rest of the World. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. Read more: https://databridgemarketresearch.com/global-self-injectionsmarket-poised-grow-22-6/ The key players operating in this market are Abbvie, Inc., Antares Pharma, 3M, Becton Dickinson & Company, Baxter International Inc., Penjet Corporation, PharmaJet, GerresheimerAG,Pfizer Inc.,Terumo Corporation, Mylan N.V.,SHL Group,Bespak, Janssen Biotech Inc., Insulet Corporation, Unilife Corporation, West Pharmaceutical Services, Inc., Ypsomed, Eli lilly and Company,Haselmeier AG, Alkermes,AptarPharma,Credence MedSystems, Inc., SchottAG,Ypsomed, Owen Mumford Ltd., Glide Technologies,among other companies. About Data Bridge Market Research: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Contact Info: Ravi Dubey Office Number 317, Amanora Chambers, Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India Toll Free: +1-888-387-2818 Mail: sales@databridgemarketresearch.com LinkedIn:https://www.linkedin.com/company/data-bridge-marketresearch?trk=nav_account_sub_nav_company_admin Dallas, TX, February 24, 2017 --( PR.com )-- Global self-injections market is expected to reach USD 119.5 billion by 2024, from USD 23.4 billion in 2016 growing at the CAGR of 22.6% in the forecast period 2017 to 2024.The self-injections market is segmented based on type, dosage form, therapeutic application, route of administration, end-user, distribution channel, and geography.On the basis of type, the global self-injections market is segmented into devices and formulations. The devices market is segmented into needle-free injectors, auto injectors, pen injectors, wearable injectors, and other devices.The needle-free injectors market is further segmented on the basis of product, technology, and usability. The product segment is categorized into fillable and prefilled.The auto-injectors market is segmented into product, technology, design, and usability. The product segment is categorized into fillable and prefilled.The pen-injectors market is segmented into product, design, and usability. The product segment is categorized into single-chambered and dual-chambered. The design segment is further categorized into standard and customized.Based on therapeutic application, the market is segmented intoautoimmunediseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, and others. The market is also segmented based on dosage formintosingle dose and multi-dose.On the basis of route of administration, the market is segmented into skin, circulatory /musculoskeletal, organs, and central nervous system.On the basis of end-user, the market is segmented into patient, physicians, home care settings and, others. The market is also segmented on the basis of distribution channel into hospital pharmacies, private clinics, chemist, and online pharmacies.Request for sample pages: https://databridgemarketresearch.com/reports/global-self-injections-market-trends-forecast-2024/Based on geography, the self-injections market is segmented into geographical regions such as North America, Europe, Asia-Pacific, South America, Middle East and Africa and, Rest of the World. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.Read more: https://databridgemarketresearch.com/global-self-injectionsmarket-poised-grow-22-6/The key players operating in this market are Abbvie, Inc., Antares Pharma, 3M, Becton Dickinson & Company, Baxter International Inc., Penjet Corporation, PharmaJet, GerresheimerAG,Pfizer Inc.,Terumo Corporation, Mylan N.V.,SHL Group,Bespak, Janssen Biotech Inc., Insulet Corporation, Unilife Corporation, West Pharmaceutical Services, Inc., Ypsomed, Eli lilly and Company,Haselmeier AG, Alkermes,AptarPharma,Credence MedSystems, Inc., SchottAG,Ypsomed, Owen Mumford Ltd., Glide Technologies,among other companies.About Data Bridge Market Research:Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.Contact Info:Ravi DubeyOffice Number 317, Amanora Chambers,Magarpatta Road, HadapsarPune – 411028Maharashtra, IndiaToll Free: +1-888-387-2818Mail: sales@databridgemarketresearch.comLinkedIn:https://www.linkedin.com/company/data-bridge-marketresearch?trk=nav_account_sub_nav_company_admin Click here to view the list of recent Press Releases from Data Bridge Market Research


News Article | February 17, 2017
Site: marketersmedia.com

Wiseguyreports.Com Adds “Insulin Delivery Devices -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2022” To Its Research Database This report studies sales (consumption) of Insulin Delivery Devices in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Insulin Delivery Devices in these regions, from 2011 to 2021 (forecast), like Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into Insulin pumps Insulin pen Insulin syringe Insulin jet Split by applications, this report focuses on sales, market share and growth rate of Insulin Delivery Devices in each application, can be divided into Application 1 Application 2 Global Insulin Delivery Devices Sales Market Report 2017 1 Insulin Delivery Devices Overview 1.1 Product Overview and Scope of Insulin Delivery Devices 1.2 Classification of Insulin Delivery Devices 1.2.1 Insulin pumps 1.2.2 Insulin pen 1.2.3 Insulin syringe 1.2.4 Insulin jet 1.3 Application of Insulin Delivery Devices 1.3.1 Application 1 1.3.2 Application 2 1.4 Insulin Delivery Devices Market by Regions 1.4.1 United States Status and Prospect (2012-2022) 1.4.2 China Status and Prospect (2012-2022) 1.4.3 Europe Status and Prospect (2012-2022) 1.4.4 Japan Status and Prospect (2012-2022) 1.4.5 Southeast Asia Status and Prospect (2012-2022) 1.4.6 India Status and Prospect (2012-2022) 1.5 Global Market Size (Value and Volume) of Insulin Delivery Devices (2012-2022) 1.5.1 Global Insulin Delivery Devices Sales and Growth Rate (2012-2022) 1.5.2 Global Insulin Delivery Devices Revenue and Growth Rate (2012-2022) 9 Global Insulin Delivery Devices Manufacturers Analysis 9.1 Medtronic, Inc. 9.1.1 Company Basic Information, Manufacturing Base and Competitors 9.1.2 Insulin Delivery Devices Product Type, Application and Specification 9.1.2.1 Product A 9.1.2.2 Product B 9.1.3 Medtronic, Inc. Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.1.4 Main Business/Business Overview 9.2 F. Hoffmann-La Roche 9.2.1 Company Basic Information, Manufacturing Base and Competitors 9.2.2 Insulin Delivery Devices Product Type, Application and Specification 9.2.2.1 Product A 9.2.2.2 Product B 9.2.3 F. Hoffmann-La Roche Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.2.4 Main Business/Business Overview 9.3 Abbott Laboratories 9.3.1 Company Basic Information, Manufacturing Base and Competitors 9.3.2 Insulin Delivery Devices Product Type, Application and Specification 9.3.2.1 Product A 9.3.2.2 Product B 9.3.3 Abbott Laboratories Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.3.4 Main Business/Business Overview 9.4 Novo Nordisk A/S 9.4.1 Company Basic Information, Manufacturing Base and Competitors 9.4.2 Insulin Delivery Devices Product Type, Application and Specification 9.4.2.1 Product A 9.4.2.2 Product B 9.4.3 Novo Nordisk A/S Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.4.4 Main Business/Business Overview 9.5 Eli Lilly and Company 9.5.1 Company Basic Information, Manufacturing Base and Competitors 9.5.2 Insulin Delivery Devices Product Type, Application and Specification 9.5.2.1 Product A 9.5.2.2 Product B 9.5.3 Eli Lilly and Company Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.5.4 Main Business/Business Overview 9.6 Sanofi 9.6.1 Company Basic Information, Manufacturing Base and Competitors 9.6.2 Insulin Delivery Devices Product Type, Application and Specification 9.6.2.1 Product A 9.6.2.2 Product B 9.6.3 Sanofi Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.6.4 Main Business/Business Overview 9.7 Becton Dickinson 9.7.1 Company Basic Information, Manufacturing Base and Competitors 9.7.2 Insulin Delivery Devices Product Type, Application and Specification 9.7.2.1 Product A 9.7.2.2 Product B 9.7.3 Becton Dickinson Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.7.4 Main Business/Business Overview 9.8 Insulet 9.8.1 Company Basic Information, Manufacturing Base and Competitors 9.8.2 Insulin Delivery Devices Product Type, Application and Specification 9.8.2.1 Product A 9.8.2.2 Product B 9.8.3 Insulet Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.8.4 Main Business/Business Overview 9.9 B. Braun Melsungen AG 9.9.1 Company Basic Information, Manufacturing Base and Competitors 9.9.2 Insulin Delivery Devices Product Type, Application and Specification 9.9.2.1 Product A 9.9.2.2 Product B 9.9.3 B. Braun Melsungen AG Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.9.4 Main Business/Business Overview 9.10 Animas Corporation 9.10.1 Company Basic Information, Manufacturing Base and Competitors 9.10.2 Insulin Delivery Devices Product Type, Application and Specification 9.10.2.1 Product A 9.10.2.2 Product B 9.10.3 Animas Corporation Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.10.4 Main Business/Business Overview 9.11 Ypsomed Holdings AG For more information, please visit https://www.wiseguyreports.com/sample-request/967709-global-insulin-delivery-devices-sales-market-report-2017


News Article | November 10, 2016
Site: www.PR.com

Global Drug Delivery Devices Market, By Product Type (Oral Solid, Liquid, Semi-Solid), Injectable, Topical, Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare, Others), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tenders, Online Pharmacy), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) – Trends and Forecast to 2022 Dallas, TX, November 10, 2016 --( Request for sample pages: http://databridgemarketresearch.com/reports/global-drug-delivery-devices-market/ On the basis of product type the global drug delivery devices market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drugs are further sub segmented into solid drug, semi-solid drug and liquid drug. The Pulmonary drug delivery segment is further sub segmented into metered dose inhalers (MDI), dry powder inhalers (DPI) and nebulizers. Topical drug delivery segment is further sub segmented based on form into liquid, semi-solid, solid and transdermal. Based on the distribution channel the market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy. On the basis of end-users the global drug delivery devices market is segmented into hospitals, over the counter, clinics, home healthcare, community healthcare, and others. Based on geography the market is segmented into North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market shares countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa. The report includes market shares of global drug delivery devices market for North America, Europe and Asia Pacific. Read more: http://databridgemarketresearch.com/reports/global-drug-delivery-devices-market/ The key players operating in this market are Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc., Merck & Co., Sanofi, Antares Pharma, 3M, Becton Dickinson and Company, Nemera, Cima Labs, Inc., Dali Medical Devices, Alkermes, Foamis, Ypsomed, Skyepharma AG, Valeant Pharmaceuticals DSM Biomedical and Catalent, Inc. among others. About Data Bridge Market Research: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Dallas, TX, November 10, 2016 --( PR.com )-- The Global Drug Delivery Devices Market is segmented on the basis of product type, distribution channel, end-user and geography.Request for sample pages: http://databridgemarketresearch.com/reports/global-drug-delivery-devices-market/On the basis of product type the global drug delivery devices market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drugs are further sub segmented into solid drug, semi-solid drug and liquid drug. The Pulmonary drug delivery segment is further sub segmented into metered dose inhalers (MDI), dry powder inhalers (DPI) and nebulizers. Topical drug delivery segment is further sub segmented based on form into liquid, semi-solid, solid and transdermal.Based on the distribution channel the market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy.On the basis of end-users the global drug delivery devices market is segmented into hospitals, over the counter, clinics, home healthcare, community healthcare, and others.Based on geography the market is segmented into North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market shares countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa. The report includes market shares of global drug delivery devices market for North America, Europe and Asia Pacific.Read more: http://databridgemarketresearch.com/reports/global-drug-delivery-devices-market/The key players operating in this market are Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc., Merck & Co., Sanofi, Antares Pharma, 3M, Becton Dickinson and Company, Nemera, Cima Labs, Inc., Dali Medical Devices, Alkermes, Foamis, Ypsomed, Skyepharma AG, Valeant Pharmaceuticals DSM Biomedical and Catalent, Inc. among others.About Data Bridge Market Research:Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Click here to view the list of recent Press Releases from Data Bridge Market Research


(PRLEAP.COM)– According to a new series of reports on the European market for diabetes monitoring, treatment and drug delivery by iData Research ( www.idataresearch.com ), insulin patch pumps are growing in popularity due to a significantly lower initial purchase price, relative to traditional insulin pumps. The number of patch pump users is expected to continue to grow and gradually acquire significant market share in the total insulin pump market. The growth of the total traditional insulin pump market will be driven by increases in unit sales and limited by modest declines in average selling prices."Unit sales are expected to grow in response to favorable reimbursement rates and greater adoption of pump usage in Europe," explains Dr. Kamran Zamanian, CEO of iData. "Recent clinical trials have shown evidence of superior health benefits in type 2 diabetic patients on pump therapy, relative to patients on multiple daily injections. These results will contribute to the growth of the pump market and increase the possibility of reimbursement for type 2 patients."Differences in reimbursement policies will result in varying unit growth across regions in the European market. Regions with relatively low penetration rates, such as Spain and Portugal, are expected to experience higher growth than regions such as Germany, where pumps have an established market and the installed base is much larger. The insulin pump market penetration rates in Scandinavia, the Netherlands, Germany and France are historically high, rates ranging from 15% to over 30%.Traditional pumps are sold with a warranty that covers a four year product lifespan. Due to the frequent technological advancements made in this market, patients tend to replace pumps with newer models once the warranty has expired. The frequent replacement of pumps will contribute to increasing unit sales as patients adopt new products in order to benefit from smaller device sizes and new features.Medtronic is the leading competitor in the European traditional pump market, offers insulin pumps through the MiniMed® brand, which features continuous glucose monitoring integration when used with the company's Enlite® sensors. Insulet is the leading competitor in the European insulin patch pump market, whose products are distributed through Ypsomed in Europe. The company currently offers the OmniPod® System and is expected to release a new personal diabetes manager device in the near future. Their new product will feature a larger screen with touch navigation, decreased device size and Bluetooth capability to pair with DexCom's G5® CGM sensors and smartphone application. Additional competitors in the European insulin pump market include Roche, Animas, Sooil, Cellnovo and Ypsomed among others.More on the diabetes device market in Europe can be found in a series of reports published by iData Research entitled the European Market Report Suite for Diabetes Monitoring, Treatment and Drug Delivery . The suite covers reports on the following markets: blood glucose meters, blood glucose test strips, lancets and lancing devices, continuous glucose monitoring (CGM), flash glucose monitoring (FGM), insulin, insulin pens, insulin syringes and insulin pumps.The iData report series on diabetes devices covers the U.S. and 15 countries in Europe including Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and the United Kingdom. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment. To find out more about diabetes devices market data, register online or email us at info@idataresearch.net for a European Market Report Suite for Diabetes Monitoring, Treatment and Drug Delivery brochure and synopsis.iData Research ( www.idataresearch.com ) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: In-Vitro Diagnostics, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Vascular Access, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Ophthalmics, Dental Operatory Equipment and more.


News Article | October 31, 2016
Site: www.PR.com

Global Pen Needles Market, by Product Type (Standard Pen Needles, Safety Pen Needles), by Product Length (Nano Length, Medium Length, Long length), by Usability (Reusable Pen Needles, Disposable Pen Needles), by Application (Diabetes, Growth Hormone Deficiency, Others), by Therapy (Insulin, Glucagon-like peptide-1, Growth Hormones), by End-User (Hospitals, Clinics, OTC, Home Healthcare, Others), by Geography – Trends and Forecast to 2022. Dallas, TX, October 31, 2016 --( The market is segmented on the basis of product type, material, stage, connectors, and geography. Request for sample pages: http://databridgemarketresearch.com/reports/global-pen-needles-market/ On the basis of product type the Pen needles market is segmented into standard and safety pen needles. Based on product length, the market is segmented into Nano Length, Medium Length, and Long length. On the basis of usability, the market is segmented into Reusable Pen Needles, Disposable Pen Needles. Based on application, the market is segmented into Diabetes, Growth Hormone Deficiency, Others. On the basis of therapy, the market is segmented into Insulin, Glucagon-like peptide-1, Growth Hormones. Based on End-User, the market is segmented into Hospitals, Clinics, OTC, Home Healthcare, Others. Based on geography, the market is segmented into geographical regions such as North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market shares countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa. Read more: http://databridgemarketresearch.com/reports/global-pen-needles-market/ The global players operating in this market are Becton, Dickinson and Company, ADW Diabetes, Novo Nordisk, A.Menarini Diagnostics, Ulticare, Ypsomed Holding AG, Facet Technologies, B. Braun Melsungen AG, Shanghai Neo-Medical Co. Ltd, HTL-Strefa S.A., Frank Healthcare Co., Ltd, Stat Medical Devices, Inc., Terumo Corporation, Domrex Pharma Inc., Vogt Medical Vertrieb GmbH, Artsana S.p.a, Eli Lilly, Owen Mumford Ltd, KD Medical GmbH Hospital Products, Allison Medical, Inc., Digital Medics Pty Ltd, and Ultimed, Inc. among others. About Data Bridge Market Research: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Dallas, TX, October 31, 2016 --( PR.com )-- The market for Pen Needles Market is expected to reach USD 3.6 billion by 2022, growing at 11.6% during the forecast years to 2022.The market is segmented on the basis of product type, material, stage, connectors, and geography.Request for sample pages: http://databridgemarketresearch.com/reports/global-pen-needles-market/On the basis of product type the Pen needles market is segmented into standard and safety pen needles.Based on product length, the market is segmented into Nano Length, Medium Length, and Long length.On the basis of usability, the market is segmented into Reusable Pen Needles, Disposable Pen Needles.Based on application, the market is segmented into Diabetes, Growth Hormone Deficiency, Others.On the basis of therapy, the market is segmented into Insulin, Glucagon-like peptide-1, Growth Hormones.Based on End-User, the market is segmented into Hospitals, Clinics, OTC, Home Healthcare, Others.Based on geography, the market is segmented into geographical regions such as North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market shares countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa.Read more: http://databridgemarketresearch.com/reports/global-pen-needles-market/The global players operating in this market are Becton, Dickinson and Company, ADW Diabetes, Novo Nordisk, A.Menarini Diagnostics, Ulticare, Ypsomed Holding AG, Facet Technologies, B. Braun Melsungen AG, Shanghai Neo-Medical Co. Ltd, HTL-Strefa S.A., Frank Healthcare Co., Ltd, Stat Medical Devices, Inc., Terumo Corporation, Domrex Pharma Inc., Vogt Medical Vertrieb GmbH, Artsana S.p.a, Eli Lilly, Owen Mumford Ltd, KD Medical GmbH Hospital Products, Allison Medical, Inc., Digital Medics Pty Ltd, and Ultimed, Inc. among others.About Data Bridge Market Research:Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Click here to view the list of recent Press Releases from Data Bridge Market Research

Loading Ypsomed AG collaborators
Loading Ypsomed AG collaborators